Climate · binary

Hantavirus vaccine in 2026?

The market prices “Yes” at 3% (+0.1 pts in 24h). $141K traded in total, $584 in the last 24 hours. Scheduled to resolve Jan 1, 2027, per fda.gov.

Vol total$141K

Vol 24h$584

Liquidity$39K

Resolves84d

Your bet$

Every card is one question. Tap Yes if you think it happens, No if you don't. Each button shows the chance the market gives it, what your $10 becomes if you're right (stake included), and the profit. Wrong = you lose your $10, never more. No is everything that isn't Yes.

Outcomes · most likely first1 question

Hantavirus vaccine in 2026?most traded

YESIt happensNOIt doesn't

Settles: Official result · closes Jan 1, 2027.

Resolution rules (source: Polymarket)

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.